MergersAndAcquisitions
Cyril Amarchand Mangaldas advised on the Proposed Investment of ₹750 Crores in Axis Finance Limited by Kedaara Capital
The transaction involves a primary investment for a aproximate 5% stake in Axis Finance, a systemically important NBFC, and includes structuring, regulatory advisory, and multi-practice due diligence.
Cyril Amarchand Mangaldas advises Organon & Co., a global healthcare company, in its acquisition by Sun Pharmaceutical Holdings USA, Inc.
The transaction marks a significant cross-border healthcare deal involving a global pharmaceutical portfolio spanning women’s health, biosimilars, and specialty therapies.
CAM Represents KKR in Investment in Lighthouse Learning
The investment, announced on November 25, was made by funds managed by KKR along with participation from new investor PSP Investments of Canada, reinforcing confidence in India’s education sector.
Widening the Scope of Fast Track Mergers under the Companies Act, 2013: Unlocking Corporate Efficiency or Risking Oversight
by Kshitij Nair* and Khushi Agarwal**
Labour Compliance in M&A: The Missing Piece in Due Diligence
by Ketki Kulkarni*